Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical methods for analyzing tissue microarray data.

Xueli Liu1, Vladimir Minin, Yunda Huang

  • 1Department of Biostatistics, School of Public Health, UCLA, Los Angeles, California, USA.

Journal of Biopharmaceutical Statistics
|October 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and recommendations for the translation of biomarkers of aging.

Nature aging·2024
Same author

Fundamental equations linking methylation dynamics to maximum lifespan in mammals.

Nature communications·2024
Same author

Metformin decelerates aging clock in male monkeys.

Cell·2024
Same author

Dissecting the impact of differentiation stage, replicative history, and cell type composition on epigenetic clocks.

Stem cell reports·2024
Same author

Grandparents' educational attainment is associated with grandchildren's epigenetic-based age acceleration in the National Growth and Health Study.

Social science & medicine (1982)·2024
Same author

Digitising the ageing process with epigenetic clocks.

Lancet (London, England)·2024
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Statistical methods were developed to analyze challenging tissue microarray (TMA) data for biomarker discovery. These methods relate protein expression patterns to patient survival, aiding in cancer diagnosis and prognosis.

Area of Science:

  • Biostatistics
  • Computational Biology
  • Oncology Research

Background:

  • Tissue microarrays (TMAs) are high-throughput tools for studying protein expression in tissues.
  • TMAs are crucial for evaluating biomarker diagnostic and prognostic importance in diseases like cancer.
  • Analyzing TMA data presents challenges due to skewed, non-normal, and correlated covariates.

Purpose of the Study:

  • To develop and present statistical methods for analyzing tissue microarray data.
  • To relate TMA protein expression data to censored time-to-event survival data.
  • To evaluate predictive power of biomarkers and identify high-risk patient groups.

Main Methods:

  • Statistical modeling to link TMA data with time-to-event outcomes.
  • Cox regression model evaluation and validation using nonparametric bootstrap methods (e.g., concordance index).

Related Experiment Videos

  • Data mining techniques including survival trees and bump hunting (patient rule induction method) adapted for survival data.

    • Main Results:

    • Methods were successfully applied to a kidney cancer tissue microarray dataset.
    • Demonstrated how to assess if biomarker data offers predictive information beyond standard covariates.
    • Identified simple biomarker rules for characterizing high-risk patient populations.

    Conclusions:

    • The presented statistical and data mining methods effectively address the complexities of TMA data analysis.
    • These approaches enhance the evaluation of biomarker utility in cancer prognosis and diagnosis.
    • The methods facilitate the identification of predictive biomarkers and patient stratification strategies.